Furthermore, inhibition of GSH and thioredoxin antioxidant pathways or selective activation of the Akt pro-oxidant pathways led to synergistic tumor regression confirming the remarkable potency of excessive ROS when harnessed for tumor eradication (61, 62). Here, AKT1 is linked to neoplasm.